This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Neurocrine Biosciences Inc (NBIX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 44.79M 63.75M 50.11M 54.05M
Receivables 23.00K 14.09M 1.90M 4.47M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 2.70M 2.16M 1.47M 1.72M
Total Current Assets 148.46M 189.26M 132.48M 133.05M
Property, Plant & Equipment, Gross 30.10M 36.22M 36.47M 38.08M
Accumulated Depreciation & Depletion 28.33M 34.32M 34.89M 36.55M
Property, Plant & Equipment, Net 1.77M 1.90M 1.59M 1.53M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 4.44M 4.82M 4.31M 9.84M
Total Non-Current Assets 6.21M 6.72M 5.89M 11.37M
Liabilities & Shareholder Equity
Total Assets 154.68M 195.98M 138.37M 144.42M
Accounts Payable 101.00K 911.00K 1.11M 810.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 3.64M 3.72M 264.00K 3.38M
Total Current Liabilities 11.70M 15.65M 47.11M 52.78M
Long Term Debt 0.00 3.10M 0.00 0.00
Deferred Income Taxes 19.63M 22.71M 1.80M 1.41M
Other Non-Current Liabilities 2.94M 152.00K 29.38M 70.89M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 22.57M 25.96M 31.18M 72.30M
Total Liabilities 34.27M 41.61M 78.29M 125.08M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 120.41M 154.37M 60.08M 19.34M
Common Par 67.00K 66.00K 55.00K 55.00K
Additional Paid In Capital 886.10M 873.98M 784.81M 781.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -765.76M -719.67M -724.70M -762.27M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 5.00K -2.00K -87.00K -48.00K
Total Capitalization 120.41M 157.47M 60.08M 19.34M
Total Equity 120.41M 154.37M 60.08M 19.34M
Total Liabilities & Stock Equity 154.68M 195.98M 138.37M 144.42M
Total Common Shares Outstanding 67.35M 66.45M 55.26M 54.88M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 66.99M 65.62M 55.18M 52.82M
Diluted Weighted Shares Outstanding 66.99M 66.95M 56.35M 52.82M
Number of Employees 81 78 71 66
Number of Part-Time Employees 0 0 0 0

NBIX Neurocrine Biosciences Inc

Analysts Ratings for NBIX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

NBIX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs